Related Experiment Video
Updated: Aug 14, 2026

Isolation of Uterine Innate Lymphoid Cells for Analysis by Flow Cytometry
Published on: October 14, 2021
Mast cell distribution and density in the normal uterus--metachromatic staining using lectins
E Sivridis1, A Giatromanolaki, N Agnantis
1Department of Pathology, General Hospital Alexandroupolis, Democritus University of Thrace, P.O. Box 128, 68100, Alexandroupolis, Greece. esivrid@med.duth.gr
Insights
Mast cells are normal constituents of the human uterus, primarily found in the myometrium and basal layer of the endometrium. Their numbers decrease significantly before menstruation, potentially aiding uterine contractions.
Area of Science:
- Reproductive Biology
- Immunohistochemistry
- Gynecological Pathology
Background:
- Mast cells are immune cells with diverse roles in inflammation and tissue remodeling.
- Their presence and function in the normal human uterus are not fully elucidated.
- Understanding mast cell distribution is crucial for reproductive health research.
Purpose of the Study:
- To quantify and map the distribution of mast cells in the normal human uterus.
- To investigate the cyclical changes in endometrial mast cells.
- To explore the potential roles of mast cells in menstruation and implantation.
Main Methods:
- Human uterine tissues were promptly fixed.
- Biotin-labeled lectins and the avidin-biotin peroxidase complex (ABC) method were employed for staining.
- Mast cell counts per high power field (MC/HPF) were determined using Canavalia ensiformis agglutinin (Con A).
Main Results:
- Mast cells are abundant in the myometrium (inner: 17.9 MC/HPF, outer: 8.3 MC/HPF) and scarce in the endometrium (stratum basalis: 2.7 MC/HPF, stratum functionalis: 0.3 MC/HPF).
- No significant differences in mast cell counts were observed between proliferative and secretory endometrium.
- Endometrial mast cells showed reduced numbers and degranulation in the pre-menstrual phase.
Conclusions:
- Mast cells are integral components of the human uterus, with distinct distribution patterns.
- Pre-menstrual degranulation suggests a role in uterine contractions preceding menstruation.
- Paucity in the functional layer may support immune tolerance for blastocyst implantation.
Abstract:
This study investigates the number and the distribution of mast cells in the normal human uterus. Reliability of results was ensured by prompt tissue fixation and the use of biotin-labelled lectins in conjunction with the avidin-biotin peroxidase complex (ABC) method. This design revealed that mast cells are, indeed, normal constituents of the human uterus. They occur in large numbers in the myometrium, but are only scanty in the endometrium where they tend to be confined to the stratum basalis. The mean mast cell counts per high power field (MC/HPF), after staining with Canavalia ensiformis agglutinin (Con A), were 17.9MC/HPF in the inner half of the myometrium, and 8.3MC/HPF in the outer half of the myometrium; 2.7MC/HPF in the basalis, and 0.3MC/HPF in the functionalis (P<0.05). There are no apparent differences in the number of mast cells between the normal proliferative and secretory phase endometrium, however, endometrial mast cells are considerably reduced and, apparently, depleted of metachromatic granules during the immediate pre-menstrual phase of the menstrual cycle. It is presumed that this, almost exclusive, presence of mast cells in the basal layer of the endometrial matrix, combined with the discharge of their cytoplasmic granules towards the end of the cycle, may be related with the contracting process preceding menstruation. On the other hand, the relative paucity of mast cells in the functional layer may contribute to the immune tolerance of the gestational endometrium to the implantation of the blastocyst.
More Related Videos
05:16Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
Published on: August 4, 2021
08:29Measurement of Four Uterine NK Cell Subtypes Using Multiplexed Fluorescent Immunohistochemical Staining in Women with Repeated Implantation Failure
Published on: October 25, 2024